OneOncology Appoints New Board Member
In a significant move aimed at enhancing its leadership and commitment to community oncology, OneOncology has announced the appointment of Emily Z. Touloukian, DO, FASCO, as a member of its Board of Managers. Dr. Touloukian serves as the President and CEO of Coastal Cancer Center, bringing her extensive expertise in hematology and oncology to the board, enriching the physician-led platform that empowers independent medical practices.
Strengthening Physician Leadership
With Dr. Touloukian's addition, OneOncology now boasts nine physicians on its 14-member Board, underscoring its dedication to physician leadership. She joins Eric Mininberg, MD, President of Piedmont Cancer Institute, who was appointed earlier, along with other distinguished board members including Natalie Dickson, MD; Sen. Bill Frist, MD; Sharad Mansukani, MD; Jeff Patton, MD; John Schilling, MD; Geoff Sklar, MD; and Jeff Vacirca, MD. This strategic composition of the board is pivotal for fostering the growth of independent community practices.
Dr. Touloukian's Experience and Vision
Dr. Touloukian is not only board-certified in medical oncology, hematology, and internal medicine, but she also holds key positions on the Board of Directors for the Community Oncology Alliance. Her experience as past president of the South Carolina Oncology Society and her current role as president of the Medical Society of Horry County reflects her commitment to advancing oncology practices in the community. Commenting on her new role, Dr. Jeff Patton, CEO of OneOncology, expressed enthusiasm for Dr. Touloukian's insights and leadership, stating that her presence will greatly contribute to OneOncology's mission of empowering physician partners.
About OneOncology's Mission and Impact
OneOncology was established with a clear mission: to enhance the lives of patients facing cancer and other diseases while ensuring that community medical practices remain independent. By offering support through group purchasing, operational optimization, and clinical innovation, OneOncology plays a crucial role in improving patient access to care at lower costs compared to traditional hospital settings. The organization currently partners with approximately 29 medical practices, representing around 1,800 healthcare providers, who collectively serve about 1 million patients across 565 care sites nationwide. This extensive network amplifies the vital work being done in community oncology, reflecting a commitment to patient-centered care.
Looking Ahead
The future of OneOncology looks promising with key leadership figures like Dr. Touloukian on board, committed to transforming the landscape of cancer care. The focus remains on enhancing the support provided to community medical practices, ensuring that they thrive independently while delivering high-quality care to patients.
Frequently Asked Questions
What is the role of Dr. Touloukian at OneOncology?
Dr. Touloukian serves on the Board of Managers, contributing her medical expertise to guide the organization's mission.
Why is physician leadership important at OneOncology?
Physician leadership is crucial as it ensures that the strategies and decisions align with the needs of the medical community and enhance patient care.
How does OneOncology support community practices?
OneOncology provides support through optimized operations, group purchasing power, and facilitating clinical innovations to enhance patient access to care.
How many member practices are involved with OneOncology?
OneOncology partners with approximately 29 medical practices across the country, which include around 1,800 healthcare providers.
What sets OneOncology apart from traditional healthcare systems?
OneOncology focuses on empowering community practices to remain independent while delivering high-quality and cost-effective care compared to hospital settings.
